Clinical trial readout dates for Kiniksa Pharmaceuticals International plc, compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is December 2027.
Kiniksa Pharmaceuticals International plc reported $576M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-10-27). It reported net income of $47M for that quarter.
Recent SEC filings
8-KResults of Operations — earnings, may carry pipeline updates